BEONE MEDICINES LTD. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $50.00M, a 97.58% decline year-over-year.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $2.07B.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $2.16B.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for the quarter ending 2018-09-30 was $869.71M.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for fiscal 2021 was $50.00M, a 97.58% decline from fiscal 2020.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for fiscal 2020 was $2.07B.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for fiscal 2017 was $149.93M.
- BEONE MEDICINES LTD. stock issued during period, value, new issues for fiscal 2015 was $76.00K, a 46.10% decline from fiscal 2014.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-12-31 | $50.00M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $50.00M 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $2.07B 10-K · filed 2023-02-27 | |
| 2020-09-30 | $2.07B 10-Q · filed 2020-11-05 | |
| 2020-03-31 | $2.16B 10-Q · filed 2020-11-05 | |
| 2018-09-30 | $869.71M 10-Q · filed 2019-11-12 | |
| 2018-03-31 | $757.59M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $149.93M 10-K · filed 2020-03-02 | |
| 2015-12-31 | $76.00K 10-K · filed 2018-02-28 | |
| 2014-12-31 | $141.00K 10-K · filed 2017-03-22 |